Abstracts may be submitted for oral and poster presentations for the following topics:
AS01 PATHOGENESIS OF ATHEROSCLEROSIS
AS01.01 Endothelial cell function and biology
AS01.02 Smooth muscle cell biology
AS01.03 Macrophages in lipid metabolism and atherosclerosis
AS01.04 Inflammation, immunity and infection in atherosclerosis
AS01.05 Extracellular matrix and calcification
AS01.06 Vascular biology of the arterial wall: Miscellaneous
AS01.07 Imaging technology
AS01.08 Platelets, thrombosis and atherosclerosis
AS01.09 Aortic valve stenosis
AS01.10 Clonal Haematopoiesis
AS01.11 Plaque remodelling
AS01.12 Neuroimmune axis in atherosclerosis
AS01.13 Other
AS02 2. LIPIDS AND LIPOPROTEINS
AS02.01 Lp(a)
AS02.02 TG rich lipoproteins metabolism and lipases
AS02.03 HDL
AS02.04 Lipoprotein receptors
AS02.05 Bile acids
AS02.06 Cholesterol efflux and reverse cholesterol transport
AS02.07 Lipidomics
AS02.08 Cellular lipid metabolism and lipid droplets
AS02.09 Lipid and lipoprotein metabolism
AS02.10 Modified lipoproteins
AS02.11 Liver metabolism and steatosis
AS02.12 Adipose tissue biology and pathology
AS02.13 Incretins and lipid metabolism
AS02.14 Other
AS03 3. DYSLIPIDEMIA AND RISK FACTORS
AS03.01 Epidemiology of cardiovascular diseases and risk factors
AS03.02 Epidemiology of dyslipidemias
AS03.03 Diabetes, insulin sensitivity and resistance
AS03.04 Adipose tissue homeostasis
AS03.05 Inherited dyslipidemias
AS03.06 Gender and cardiovascular risk
AS03.07 Environmental risk factors
AS03.08 Novel risk factors and biomarkers
AS03.09 Epidemiology of socioeconomic and psychosocial risk factors
AS03.10 Coagulation
AS03.11 Gut microbiome
AS03.12 Gene editing technology
AS03.13 Genomics, GWAS and population genetics; Mendelian randomization
AS03.14 Epigenetics and microRNA
AS03.15 Gene-Environment interactions
AS03.16 Cardiometabolic factors implicated in the development of heat failure with preserved ejection fraction
AS03.17 Other
AS04 4. CLINICAL VASCULAR DISEASE
AS04.01 Coagulation and Thrombosis
AS04.02 Endothelial dysfunction; Clinical assessment
AS04.03 NASH and other ectopic lipid diseases
AS04.04 Chronic kidney disease and nephropathies
AS04.05 Diabetes; macro- and microangiopathies
AS04.06 Aneurysms and other non-atherosclerotic arteriopathies
AS04.07 Nutrition, nutraceuticals
AS04.08 Bariatric surgery
AS04.09 Lipid-lowering therapies
AS04.10 Anti-thrombotic therapies
AS04.11 Anti-inflammatory therapies
AS04.12 Prevention and treatment of cardiovasculardisease; miscellaneous
AS04.13 New lipid lowering therapies
AS04.14 SGTL2 inhibitor and cardiovascular diseases
AS04.15 Other
